An obese patient with slowly progressive type 1 diabetes diagnosed by ketoacidosis

Internal Medicine

Volumn 49, Issue 5, 2010, Pages 393-395

  Negishi, Mayumi ^a,b   Shimomura, Kenju ^c   Proks, Peter ^c,d   Akuzawa, Masako ^a   Takahashi, Masaki ^a   Mori, Masatomo ^b   Shimomura, Yohnosuke ^a   Kobayashi, Isao ^a,e  

^a Hidaka Hospital   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d INSTITUTE OF CHEMISTRY   (Slovakia)

^e GUNMA PAZ UNIVERSITY   (Japan)

Author keywords

Diabetic ketoacidosis; Obesity; Slowly progressive insulin dependent diabetes mellitus

Indexed keywords

C PEPTIDE; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY;

AGED; ANAMNESIS; ARTICLE; BODY MASS; BODY WEIGHT; CASE REPORT; CONVALESCENCE; DISEASE COURSE; FEMALE; HOSPITAL ADMISSION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KETOACIDOSIS; LABORATORY TEST; OBESITY; PHYSICAL EXAMINATION; VITAL SIGN; WEIGHT REDUCTION;

AGED; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC KETOACIDOSIS; DISEASE PROGRESSION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; OBESITY;

EID: 77749313252     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.2843     Document Type: Article

References (11)

1. Zimmet P, Tuomi T, Mackay I, et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11: 299-303, 1994.
2. Mølbak A, Christau B, Marner B, Borch-Johnsen K, Nerup J. Incidence of insulin-dependent diabetes mellitus in age groups over 30 years in Denmark. Diabet Med 11: 650-655, 1994.
3. Suzuki C, Hirai Y, Terui K, Kohsaka A, Akagi T, Suda T. Slowly progressive type 1 diabetes mellitus associated with vitiligo vulgaris, chronic thyroiditis, and pernicious anemia. Intern Med 43: 1183-1185, 2004.
4. Stenström G, Gottsäter A, Bakhtadze E, Berger B, Sundkvist G. Latent autoimmune diabetes in adults: definition, prevalence, betacell function, and treatment. Diabetes 54 Suppl 2: S68-S72, 2005.
5. Kobayashi T, Nakanishi K, Okubo M, Murase T, Kosaka K. GAD antibodies seldom disappear in slowly progressive IDDM. Diabetes Care 19: 1031, 1996.
6. Bruno G, Cerutti F, Merletti F, et al. Residual beta-cell function and male/female ratio are higher in incident young adults than in children: the registry of type 1 diabetes of the province of Turin, Italy, 1984-2000. Diabetes Care 28: 312-317, 2005.
7. Bruno G, Runzo C, Cavallo-Perin P, et al. Incidence of type 1 and type 2 diabetes in adults aged 30-49 years: the population-based registry in the province of Turin, Italy. Diabetes Care 28: 2613-2619, 2005.
8. Borg H, Arnqvist H, Björk E, et al. Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15-34 yrs) in the Diabetes Incidence Study in Sweden (DISS). Diabetologia 46: 173-181, 2003.
9. Sämann A, Mühlhauser I, Bender R, Hunger-Dathe W, Kloos C, Müller U. Flexible intensive insulin therapy in adults with type 1 diabetes and high risk for severe hypoglycemia and diabetic ketoacidosis. Diabetes Care 29: 2196-2199, 2006.
10. Suzuki T, Takahashi K, Miyamoto S, et al. "Type 1 on type 2" diabetes mellitus: autoimmune type 1 diabetes superimposed on established type 2 diabetes. Intern Med 46: 1957-1962, 2007.
11. Borg H, Gottsäter A, Fernlund P, Sundkvist G. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 51: 1754-1762, 2002.